TELO: TELOMIR PHARMACEUTICALS INC Stocks News on June 29, 2025

TELO

ACCESS Newswire

11 days ago

Telomir Pharmaceuticals Prevents Cellular Aging in Patient-Derived Cells from Children with Progeria - an Ultra-Rare Genetic Disorder that Causes Rapid Aging

TELO

Benzinga

11 days ago

EXCLUSIVE: Telomir Pharmaceuticals Says Preclinical Drug Candidate Prevents Premature Aging In Patient-Derived Cells From Children With Progeria

TELO

Zacks Small Cap Research

11 days ago

TELO Reverses Damage in Progeria Cells

TELO

Insider Monkey

16 days ago

TELO Rises on Promising Telomir-1 Preclinical Results

TELO

MT Newswires

18 days ago

Telomir Says Telomir-1 'Significantly Reversed' Wilson's Disease Symptoms in Animal Model

TELO

ACCESS Newswire

18 days ago

Telomir Pharmaceuticals Announces Telomir-1 Demonstrates Dose-Dependent Restoration of Neurological, Liver and Kidney Functions in Preclinical Wilson's Disease Model

TELO

Zacks Small Cap Research

18 days ago

TELO Continues Trend of Significant Trial Announcements

TELO

MT Newswires

24 days ago

Telomir Says Lead Candidate Telomir-1 Restored Gene Regulation in Animal Model of Werner Syndrome

TELO

ACCESS Newswire

24 days ago

Telomir Pharmaceuticals Announces Telomir-1 Resets the Body's Epigenetic Clock, Reverses DNA Methylation, and Restores Youthful Gene Regulation in an Ultra-Rare Accelerated Aging Animal Model of Werner Syndrome

TELO

Benzinga

24 days ago

EXCLUSIVE: Telomir Pharmaceuticals Lead Drug Shows Promising Signs In Animal Study For Rare Premature Aging Disorder

TELO

Zacks Small Cap Research

24 days ago

TELO Data Indicates Aging Reversal Potential

TELO

ACCESS Newswire

a month ago

Telomir Pharmaceuticals to Participate in BIO 2025 in Boston as Company Prepares for IND Submission and Advances Breakthrough Longevity Platform

TELO

ACCESS Newswire

a month ago

Telomir Pharmaceuticals Confirms Telomir-1 Restores Vision and Retinal Structure in Age-Related Macular Degeneration (AMD) Animal Model Using FDA-Recognized Surrogate Endpoints

TELO

Zacks Small Cap Research

a month ago

TELO Produces Results with Exciting AMD Implications

TELO

MT Newswires

a month ago

Telomir Pharmaceuticals Obtains $3 Million in Straight Equity Sale

TELO

ACCESS Newswire

a month ago

Telomir Pharmaceuticals Secures $3 Million at a Premium in Straight Equity Sale Involving No Warrants to Advance Rare Disease IND

TELO

Benzinga

a month ago

EXCLUSIVE: Telomir Pharma To Raise $3 Million Via Equity Financing To Fund Its Rare Disease IND

TELO

ACCESS Newswire

a month ago

Telomir Pharmaceuticals Adds Telomir-Ag2 as a Novel Drug Candidate to Pipeline Following Breakthrough Efficacy Against MARSA and Drug-Resistant Infections, Targeting a $30B+ Antimicrobial Market Opportunity

TELO

Zacks Small Cap Research

a month ago

TELO Announces Exciting Discovery

TELO

ACCESS Newswire

2 months ago

Telomir Pharmaceuticals Demonstrates Telomir-1 Reverses Key Drivers of Cellular Decline in Human Cell Lines Supporting Therapeutic Potential in Autism and Spasmodic Dysphonia

TELO

Zacks Small Cap Research

2 months ago

TELO Announces Promising Aging Reversal Test Results

TELO

MT Newswires

3 months ago

Telomir Pharmaceuticals Says Telomir-1 Reduces Tumor Size in Prostate Cancer Animal Model

TELO

ACCESS Newswire

3 months ago

Telomir Pharmaceuticals Announces Significant Anti-Cancer Effects in Prostate Cancer Animal Model Using Highly Aggressive Human Prostate Cancer Cells

TELO

Zacks Small Cap Research

3 months ago

TELO Study Shows Cancer-Related Breakthrough

TELO

ACCESS Newswire

4 months ago

Telomir Pharmaceuticals Announces Breakthrough: Telomir-1 Reverses Calcium Dysregulation, the Hidden Driver of Aging and Disease, in Multiple Human Cell Lines

3 US Penny Stocks To Consider In February 2025

TELO

Simply Wall St.

4 months ago

3 US Penny Stocks To Consider In February 2025

TELO

MT Newswires

4 months ago

Telomir Pharmaceuticals Says Telomir-1 Compound Stabilizes Silver for Advanced Medical Applications

TELO

ACCESS Newswire

4 months ago

Telomir Pharmaceuticals Achieves Breakthrough in Silver Ion Stabilization, Unlocking a Multi-Billion-Dollar Medical Market

TELO

Zacks Small Cap Research

4 months ago

TELO Announces Breakthrough

TELO

Benzinga

4 months ago

Telomir Pharmaceuticals Seeks To Tap Multi-Billion-Dollar Market With Breakthrough In Silver Ion Stabilization For Antibacterial Treatment, Tissue Regeneration

TELO

ACCESS Newswire

4 months ago

Telomir Pharmaceuticals Announces Significant Reduction of Oxidative Stress in Human Retinal Cell Lines, Advancing Potential Treatment for Age-Related Macular Degeneration (AMD)

TELO

Zacks Small Cap Research

4 months ago

TELO Again Announces Breakthrough Results

TELO

Zacks Small Cap Research

5 months ago

TELO Improves Balance Sheet

TELO

ACCESS Newswire

5 months ago

Telomir Pharmaceuticals Announces Breakthrough Results With Telomir-1 Fully Reversing Oxidative Stress in Human Cell Lines and Exploring Potential as a Treatment for Avian Influenza (Bird Flu) and Other Viruses

TELO

Zacks Small Cap Research

5 months ago

TELO Treatment Amazes in Preclinical Trial

TELO

Simply Wall St.

5 months ago

Telomir Pharmaceuticals, Inc.'s (NASDAQ:TELO) biggest owners are retail investors who got richer after stock soared 13% last week

TELO

Zacks Small Cap Research

6 months ago

Zacks Small Cap Research 2024 Initiations and Best Ideas for 2025

TELO

ACCESSWIRE

6 months ago

Telomir Pharmaceuticals Confirms Lifespan Restoration and Normalization of Accelerated Aging in Preclinical Model of Progeria (A Rare Genetic Disorder Causing Rapid Aging)

TELO

Zacks Small Cap Research

6 months ago

TELO Continues to Impress

TELO

ACCESSWIRE

6 months ago

Telomir Pharmaceuticals Confirms Copper Binding Capabilities of Telomir-1 and Expands Pipeline Into Wilson's Disease

TELO

Benzinga

6 months ago

EXCLUSIVE: Telomir Pharmaceuticals Reports Potential Of Telomir-1 For Wilson's Disease

TELO

ACCESSWIRE

7 months ago

Telomir Pharmaceuticals Raises $1 Million at $7 per Share in a No-Warrant, Restricted Common Stock Deal, Representing a 20% Premium to Closing Price

TELO

ACCESSWIRE

7 months ago

Telomir Pharmaceuticals Announces Reversal of Key Type 2 Diabetes Parameters in Groundbreaking Preclinical Study With Telomir-1

TELO

Zacks Small Cap Research

7 months ago

TELO Test Results Continue to Excite

TELO

MT Newswires

7 months ago

Sector Update: Health Care Stocks Advance Late Afternoon

TELO

MT Newswires

7 months ago

Sector Update: Health Care Stocks Climb Thursday Afternoon

TELO

MT Newswires

7 months ago

Sector Update: Health Care

TELO

MT Newswires

7 months ago

Telomir Pharmaceuticals Says Telomir-1 Preclinical Data Show Age Reversal; Shares Rise

TELO

ACCESSWIRE

7 months ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1

TELO

Zacks Small Cap Research

7 months ago

Initiating Coverage: TELO Developing Life-Changing Therapy

TELO

ACCESSWIRE

9 months ago

Telomir Pharmaceuticals Special Advisor Dr. Michael Roizen to Discuss Telomir-1 and the Science of Longevity on Health Uncensored With Dr. Drew on the Fox Business Network This Sunday

TELO

Simply Wall St.

9 months ago

Telomir Pharmaceuticals Insider Ups Holding During Year

TELO

ACCESSWIRE

10 months ago

Telomir Pharmaceuticals Appoints Dr. Itzchak Angel, Former Head of Pharmacology at Synthelabo (Now Sanofi-Aventis), to Lead IND and INAD Applications for Human and Veterinary Indications

TELO

ACCESSWIRE

10 months ago

Telomir Pharmaceuticals Featured in Local ABC Exclusive Showing Positive Outcomes of Proposed Age Reversal Pill in Dogs

TELO

MT Newswires

a year ago

Telomir Pharmaceuticals' CEO Christopher Chapman Dies; Erez Aminov to Succeed

TELO

GlobeNewswire

a year ago

Telomir Pharmaceuticals Mourns the Passing of Chairman and CEO Dr. Christopher Chapman

TELO

Simply Wall St.

a year ago

Individual investors are Telomir Pharmaceuticals, Inc.'s (NASDAQ:TELO) biggest owners and were rewarded after market cap rose by US$24m last week

TELO

MT Newswires

a year ago

Telomir Pharmaceuticals Joins Russell 3000, Microcap Indexes

TELO

GlobeNewswire

a year ago

Telomir Pharmaceuticals Added to Membership of Russell 3000 and Russell Microcap Indexes

TELO

GlobeNewswire

a year ago

Telomir Pharmaceuticals Scientific Advisor to Participate in Drug Information Association 2024 Global Annual Meeting Panel

Italian energy company targets Britain for fleet of 20 mini-nukes

TELO

The Telegraph

a year ago

Italian energy company targets Britain for fleet of 20 mini-nukes

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend

TELO

Simply Wall St.

a year ago

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?

TELO

Simply Wall St.

a year ago

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks

TELO

Simply Wall St.

a year ago

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

TELO

Motley Fool

a year ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Should You Be Adding Mueller Water Products (NYSE:MWA) To Your Watchlist Today?

TELO

Simply Wall St.

a year ago

Should You Be Adding Mueller Water Products (NYSE:MWA) To Your Watchlist Today?

Graham Full Year 2024 Earnings: EPS: US$0.42 (vs US$0.035 in FY 2023)

TELO

Simply Wall St.

a year ago

Graham Full Year 2024 Earnings: EPS: US$0.42 (vs US$0.035 in FY 2023)

Seoul resumes loudspeaker propaganda against North

TELO

AFP

a year ago

Seoul resumes loudspeaker propaganda against North

Lotto 6/49 - $64 million up for grabs in the next draw!

TELO

CNW Group

a year ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

TELO

Simply Wall St.

a year ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North

TELO

AFP

a year ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

TELO

Simply Wall St.

a year ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

TELO

Simply Wall St.

a year ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

TELO

Barrons.com

a year ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

TELO

Simply Wall St.

a year ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

TELO

Simply Wall St.

a year ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

TELO

GlobeNewswire

a year ago

Telomir Pharmaceuticals Announces Two Pivotal Milestones for Lead Product Candidate Telomir-1

New to The Street TV Announces Episode 575 with its Four Business Guest Interviews, Airs as Sponsored Programming on Bloomberg TV, Saturday, May 25, 2024, at 6:30 PM ET

TELO

GlobeNewswire

a year ago

New to The Street TV Announces Episode 575 with its Four Business Guest Interviews, Airs as Sponsored Programming on Bloomberg TV, Saturday, May 25, 2024, at 6:30 PM ET

TELO

GlobeNewswire

a year ago

Telomir Pharmaceuticals, Inc. Signs Media Deal with New to The Street for Network Interview Broadcasts, Billboards, and TV Commercial Support

TELO

GlobeNewswire

a year ago

Telomir Pharmaceuticals Unveils Compelling Pre-clinical Data on Age-Reversal Drug Telomir-1 at National Press Club Event in Washington, D.C.

TELO

GlobeNewswire

a year ago

Telomir Pharmaceuticals’ Anti-Aging Expert and NYT Bestselling Author Michael F. Roizen, MD, to Present Promising Pre-Clinical Data for Age-Reversal Drug Telomir-1 at the National Press Club in Washington, DC, on April 15, 2024

TELO

GlobeNewswire

a year ago

UPDATE – Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in Canines

TELO

GlobeNewswire

a year ago

Telomir Pharmaceuticals Announces Collaboration with Argenta to Study Osteoarthritis in Canines

TELO

GlobeNewswire

a year ago

Telomir Pharmaceuticals Releases New Pre-Clinical Data for Telomir-1 to Be Presented at the Global Longevity Federation Conference in Las Vegas on March 26th

TELO

GlobeNewswire

a year ago

Telomir Pharmaceuticals Uses AI Testing Models to Show its Lead Product Candidate’s Potential in DNA Age Reversal Science

TELO

GlobeNewswire

a year ago

Telomir Pharmaceuticals Presents Promising Pre-Clinical Data For Its Lead Development Product at Singapore Conference

TELO

GlobeNewswire

a year ago

Michael F. Roizen, MD to Increase Activities with Telomir Pharmaceuticals as Special Advisor on Age Reversal

TELO

GlobeNewswire

a year ago

Latest TELOMIR PHARMACEUTICALS INC (TELO) News on June 29, 2025

Share on Social Networks: